Excess body weight earlier in life may have greater influence on pancreatic cancer mortality risk
Click Here to Manage Email Alerts
ATLANTA — Excess body weight before age 50 years may increase pancreatic cancer mortality risk to a greater degree than excess weight at older ages, according to results from the Cancer Prevention Study II presented at American Association for Cancer Research Annual Meeting.
“Pancreatic cancer rates have been steadily increasing since the early 2000s,” Eric J. Jacobs, PhD, senior scientific director of epidemiology research at American Cancer Society, said in a press release. “We’ve been puzzled by that finding because smoking — a major risk factor for pancreatic cancer — is declining.”
Although pancreatic cancer is relatively rare, representing a little more than 3% of all new cancer cases, it is a particularly fatal, with only 8.5% of patients achieving 5-year survival. It is the third leading cause of cancer death in the United States, after lung and colon cancer.
Previous studies have found weak associations between BMI and risk for pancreatic cancer; however, most of these studies measured BMI in older adulthood, which may reflect body fat gained too late to affect risk over an average lifetime.
In the nationwide, prospective cohort study, Jacobs and colleagues evaluated data on 963,317 adults aged 30 to 89 years at the time of enrollment in American Cancer Society’s Cancer Prevention Study II, which followed participants from 1982 through 2014. Researchers calculated BMI from height and weight at time of enrollment.
During follow-up, 8,354 participants died of pancreatic cancer.
The researchers used multivariable proportional hazards regression models to determine HRs for BMI. Additionally, they used HRs from Cancer Prevention Study II and BMI data from National Health and Nutrition Examination Surveys to determine population-attributable fractions by birth cohort.
Results showed declines in HRs with increasing age at BMI assessment. An increase of five BMI units appeared associated with the following HRs at age of assessment: aged 30 to 49 years, 1.25 (95% CI, 1.18-1.33); aged 50 to 59 years, 1.19 (95% CI, 1.14-1.23); aged 60 to 69 years, 1.14 (95% CI, 1.08-1.21), and aged 70 to 89 years, 1.13 (95% CI, 1.02-1.26; P for trend = .005).
More recent U.S. birth cohorts showed a substantially higher prevalence of obesity in early middle age than earlier cohorts. The researchers then estimated that, based on a HR of 1.25 per five BMI units at age 45 years, 28% of pancreatic cancer deaths among Americans born between 1970 and 1974 will be attributable to BMI levels of 25 kg/m2 or greater. This is nearly double the corresponding percentage among those born in the 1930s, who were less inclined to be obese in early middle age.
“Our results strongly suggest that to stop and eventually reverse recent increases in pancreatic cancer rates, we will need to do better in preventing excess weight gain in children and younger adults, an achievement which would help prevent many other diseases as well,” Jacobs said in the press release. – by Jennifer Byrne
Reference:
Jacobs EJ, et al. Abstract 3281/28. Presented at: AACR Annual Meeting; March 29-April 3, 2019; Atlanta.
Disclosures: Jacobs and the other study authors report no relevant financial disclosures.